… B Kevin Park, Neil R Kitteringham, and Paul M O'Neill … M. 1998. Occurrence of the NIH
shift upon the cytochrome P450-catalyzed in vivo and in vitro aromatic ring hydroxylation of …

Despite international efforts to ‘roll back malaria’ the 2008 World Malaria Report revealed
the disease still affects approximately 3 billion people in 109 countries; 45 within the WHO …

Currently, nearly two billion people are at risk of contracting malaria and the incidence of
this disease is dramatically increasing because many Plasmodium falciparum strains, the …

The SARS-CoV-2 pandemic has triggered global efforts to develop therapeutics. The main
protease of SARS-CoV-2 (M pro ), critical for viral replication, is a key target for therapeutic …

The 4-aminoquinoline chloroquine (1) can be considered to be one of the most important
synthetic chemotherapeutic agents in history. Since its discovery, chloroquine has proved to be …

The artemisinin (ART)-based antimalarials have contributed significantly to reducing global
malaria deaths over the past decade, but we still do not know how they kill parasites. To gain …

There is a rapidly expanding literature on the in vitro antiviral activity of drugs that may be
repurposed for therapy or chemoprophylaxis against severe acute respiratory syndrome‐…

Resistance to pyrethroid insecticides in the malaria vector Anopheles gambiae is a major
threat to malaria control programmes. Cytochome P450-mediated detoxification is an important …

Evidence is reviewed elucidating the mechanism of iron-induced triggering of antimalarial
trioxanes. As prodrugs, trioxanes undergo homolytic, inner-sphere, reductive cleavage by …

Artemisinin and its derivatives are currently recommended as first-line antimalarials in
regions where Plasmodium falciparum is resistant to traditional drugs. The cytotoxic activity of …